Companies
HQSan Francisco
Employees11-50
Funding$230M
Valuation$1.3B
Revenue$1M ARR
14 active roles
Healthcare AIFoundation Model ProviderB2B SaaSSeries B$200M-$1B
About
Chai Discovery develops AI-based platforms for molecular design and drug discovery, including foundation models for molecular structure prediction and antibody design, enabling researchers to generate and evaluate novel molecules. The company targets pharma and biotech researchers and partners with scientific teams to accelerate discovery workflows.
Active Roles
14Key Investors
Emerson Collective, General Catalyst, Glade Brook Capital Partners, Oak HC/FT, Thrive Capital